News

Dr. Chi
Posted: 2019-06-03

The TITAN clinical trial has demonstrated that the addition of apalutamide to androgen-deprivation therapy significantly improved radiographic progression-free survival and overall survival in patients with metastatic castration-sensitive prostate cancer. These results were presented by Dr. Kim Chi at ASCO on May 31, and were written up on ASCO Daily News on June 1.  Dr.

Posted: 2019-05-04

May 4, 2019 - Dr. Martin Gleave gave the AUA 2019's Ramon Guiteras Lecture, a plenary invited lecture named after the AUA's founder. Click here to read the original story at AUA Daily News, the text of which is copied below.

Dr. Daugaard
Posted: 2019-05-03

St. Baldrick’s Foundation Awards One-of-a-Kind Grant to Aid in Childhood Cancer Research Discovery: St. Baldrick’s Robert J. Arceci Innovation Award provides scientists opportunity to pursue unrestricted research

Dr. Subramaniam
Posted: 2019-04-18

April 17, 2019 - Dr. Sriram Subramaniam has joined the University of British Columbia (UBC) as the Gobind Khorana Canada Excellence Research Chair in Precision Cancer Drug Design.

Dr. Subramaniam is recognized as a global leader in the emerging field of cryo-electron microscopy, or cryo-EM, a technology that has sparked a revolution in imaging of protein complexes. He is appointed both in the Department of Urologic Sciences and in Biochemistry and Molecular biology at UBC and is linked to the precision cancer drug design program at the Vancouver Prostate Centre.

...

Dr. Xuesen Dong
Posted: 2019-04-10

A recent publication from Dr Xuesen Dong and team is featured as...

Mr. Don Mattrick
Posted: 2019-04-05

The Vancouver Prostate Centre is pleased to announce the appointment of Don Mattrick to our Board of Directors.

Don is currently is co-founder and co-president of MdGB Capital, a private company that manages a group assets and operating companies throughout North America.

Dr. Gleave at the VPC
Posted: 2019-04-01

The UBC Faculty of Medicine today published "Translating research to treat prostate cancer" - a profile of the translational research breakthroughs being made at our Centre. Featuring our Executive Director Dr. Gleave, the article discusses the innovative potential therapeutics discovered by Drs. Rennie, Cherkasov and Zoubeidi.

Posted: 2019-02-25

February 25, 2019 - Scientists at the University of British Columbia have discovered a new protein “switch” that could stop the progression of blood-poisoning, or sepsis, and increase the chances of surviving the life-threatening disease.

Dr. Amina Zoubeidi
Posted: 2019-02-15

Dr. Amina Zoubeidi was featured in articles on VCHRI News and Prostate Cancer Canada on February 11, 2019, the International Day of Women and Girls in Science.

The VCHRI News article, "Ask an expert: Who runs the (science) world?" contains interviews with three researchers at VCHRI who share their experiences and offer advice for the next generation of women scientists.

Dr. Wang and laboratory
Posted: 2019-01-25

Dr YZ Wang and his co-applicants Drs Ci, He and Lin were the recipients of a five-year CIHR Project Grant (Fall 2018 competition) for their proposal titled "Function and therapeutic potential of SUV420H2 in neuroendocrine prostate cancer."

Three VPC trainees received Prostate Cancer Foundation BC research grants:

A World Class Centre

The Vancouver Prostate Centre (VPC) has a track record of success that has earned it a reputation as one of the world’s most respected cancer facilities. It is a National Centre of Excellence and a designated Centre of Excellence for Commercialization and Research.

Employment

Work at the Vancouver Prostate Centre

Tuesday, September 20, 2022

Dr Mads Daugaard develops an AI cell analytics app which could supercharge biotechnology research

Wednesday, July 20, 2022

With just a tablespoon of blood, B.C. researchers aim to transform cancer treatment